bioRxivImmunology
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
H. Zhao, X. Shao, Y. Yu, L. Huang, N. P. Amor, K. Guo, C. Weng, W. Zhao, A. Yang, J. Hu, H. Yang, Z. Liu, Q. Han, L. Shi, S. Sun, J. Zhang, Y. Yang, A. Lin
Abstract
BRIEF ABSTRACTHere we report on the development and comprehensive evaluations of an mRNA vaccine for chronic hepatitis B (CHB) treatment. In two different HBV carrier mouse models generated by viral vector-mediated HBV transfection (pAAV-HBV1.2 and rAAV8-HBV1.3), this vaccine demonstrates sufficient and persistent virological suppression, and robust immunogenicity in terms of induction of strong innate immune activation, high-level virus-specific antibodies, memory B cells and T cells. mRNA platform therefore holds prospects for therapeutic vaccine development to combat CHB.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A multivalent mRNA-LNP therapeutic vaccine with broad cross-genotype immunogenicity elicits clearance of HBV infected hepatocytes
Daniel L. Makrinos, Yanbo Sun, … Simone Pecetta·bioRxiv·Dec 5, 2025
- mRNA-LNP vaccines against Hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models
María José Limeres, Rocío Celeste Gambaro, … Maximiliano L. Cacicedo·Molecular TherapyPeer-reviewed·Jun 14, 2025
- Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B
T. O. Yarovinsky, S. W. Mason, … V. Nakaar·bioRxiv·Feb 19, 2019
- Prophylactic and therapeutic HBV vaccination by an HBs-expressing cytomegalovirus vector lacking an interferon antagonist
H. Huang, J. Liu, … M. Trilling·bioRxiv·Jan 29, 2020
- Therapeutic Potential of the Novel Monoclonal Antibody 7-4G against HBsAg in a Mouse Model of Chronic Hepatitis B Virus Infection
Maidina Abuduwaili, Grace Naswa Makokha, … Kazuaki Chayama·bioRxiv·Jul 26, 2026
- Sustained liver HBsAg loss and clonal T and B cell expansion upon therapeutic DNA vaccination require low HBsAg levels
N. Conceicao-Neto, W. Pierson, … E. Van Gulck·bioRxiv·Sep 4, 2023